Cytokinetics eps
WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. As a leader in muscle biology and the mechanics of … WebCytokinetics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CYTK financial statements in full. ... Qtr. EPS Est.-1.21 Q4 2024: Qtr. Year Ago-0.36 Q4 ...
Cytokinetics eps
Did you know?
WebCytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. WebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2024, as a material inducement to their …
WebApr 13, 2024 · During the same quarter in the previous year, the firm posted ($0.36) EPS. Research analysts predict that Cytokinetics, Incorporated will post -4.4 earnings per share for the current fiscal year. Insiders Place Their Bets. In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday ... WebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and …
WebOct 14, 2024 · Cytokinetics is a member of our Medical group, which includes 1189 different companies and currently sits at #3 in the Zacks Sector Rank. ... The consensus estimate for Humana's current year EPS ... WebApr 9, 2024 · Cytokinetics (NASDAQ:CYTK – Get Rating) last issued its quarterly earnings results on Wednesday, March 1st.The biopharmaceutical company reported ($1.45) EPS for the quarter, missing analysts ...
WebDiluted EPS (ttm)-4.33. Dividends Per Share. N/A. Dividend Yield. N/A. Ex-Dividend Date. N/A. ... Cytokinetics, a biotechnology company, had hoped that by focusing on improving the function of ... how to store buttercream icingWebMar 31, 2024 · Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised. Careers; Contact Us; Our Focus. We are developing … how to store buttercup squash for winterWebCytokinetics eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. Compare CYTK With Other Stocks From: To: Zoom: -6 -4 -2 0 2 Trailing 12 Months read them and weep meaningWebFind the latest Revenue & EPS data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. read them in spanishWebEPS for Cytokinetics (CYTK) EPS in 2024 (TTM): -$4.25. According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -$4.25. In 2024 the company … how to store byte array in javaWebApr 6, 2024 · EPS-$4.25; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 10.34M 03/15/23 % of Float Shorted 11.58%; Average Volume 992.07K; ... Cytokinetics, Inc. is a biopharmaceutical company ... read theory answers grade 11 quizletWebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … how to store buttermilk